Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
CureVac BV - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
CVAC
Nasdaq
8731
https://www.curevac.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for CureVac BV
CureVac N.V. (NASDAQ:CVAC) Q4 2023 Earnings Call Transcript
- Apr 25th, 2024 5:30 pm
CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Business Update
- Apr 24th, 2024 11:30 am
CureVac Appoints Thaminda Ramanayake as New Chief Business Officer
- Apr 24th, 2024 11:20 am
CureVac Announces Start of Combined Phase 1/2 Study in Avian Influenza (H5N1); Development in Collaboration with GSK
- Apr 24th, 2024 11:20 am
CureVac to cut costs in restructuring
- Apr 24th, 2024 10:22 am
CureVac N.V. (NASDAQ:CVAC) stock most popular amongst private equity firms who own 31%, while individual investors hold 30%
- Apr 23rd, 2024 3:00 pm
CureVac to Report Fourth Quarter and Full-Year 2023 Financial Results and Business Update on April 24, 2024
- Apr 18th, 2024 11:15 am
CureVac and MD Anderson Enter Strategic Collaboration to Develop Novel Cancer Vaccines
- Apr 16th, 2024 11:15 am
CureVac Announces Promising Phase 2 Interim Data from Seasonal Influenza Vaccine Development Program in Collaboration with GSK
- Apr 4th, 2024 11:15 am
Here's Why We're Watching CureVac's (NASDAQ:CVAC) Cash Burn Situation
- Feb 1st, 2024 10:13 am
Down -14.25% in 4 Weeks, Here's Why You Should You Buy the Dip in CureVac N.V. (CVAC)
- Jan 26th, 2024 2:35 pm
Down -15.09% in 4 Weeks, Here's Why You Should You Buy the Dip in CureVac N.V. (CVAC)
- Jan 25th, 2024 2:35 pm
CureVac Announces Positive Phase 2 Interim Data from COVID-19 Vaccine Development Program in Collaboration with GSK Providing Strong Validation of Proprietary Technology Platform
- Jan 5th, 2024 12:30 pm
13 Best Get Rich Quick Stocks To Buy
- Dec 30th, 2023 1:49 pm
These Analysts Just Made A Huge Downgrade To Their CureVac N.V. (NASDAQ:CVAC) EPS Forecasts
- Dec 22nd, 2023 11:04 am
Why Is COVID-19 Vaccine Player CureVac Stock Plummeting Today?
- Dec 19th, 2023 5:31 pm
CureVac Announces Decision of German Federal Patent Court in Broad Patent Litigation with BioNTech SE
- Dec 19th, 2023 2:35 pm
UPDATE 2-German court quashes CureVac patent after challenge by BioNTech
- Dec 19th, 2023 2:12 pm
Are Investors Undervaluing CureVac N.V. (NASDAQ:CVAC) By 26%?
- Dec 12th, 2023 3:39 pm
Can CureVac N.V. (CVAC) Climb 191.74% to Reach the Level Wall Street Analysts Expect?
- Nov 21st, 2023 2:55 pm
Scroll